The ascendancy of Viagra and its effect on the pharmaceutical landscape presents a complex question for investors. While the first sales figures were impressive, the patent has expired, leading to a flood of generic alternatives that are eroding earnings. In addition, the market is facing difficulties related to population trends and evolving he… Read More